Disposable Infusion Catheter Kit Size, Share & Forecast Analysis 2025–2033

Disposable Infusion Catheter Kit by Application (Blood Product Transfusion, Administration of Medications, Diagnostic), by Types (Peripheral Intravenous Catheter Kit, Central Venous Catheter Kit, Midline Catheter Kit), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 88

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 7.5%

Historical Range: 2020 - 2025

Dec 15, 2025Updated: Jun 8, 2026

Pages: 88

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 7.5%

Historical Range: 2020 - 2025

Loading report content...

Loading report...

Disposable Infusion Catheter Kit Market Size | CAGR 7.5 Forecast 2033

Disposable Infusion Catheter Kit Size, Share & Forecast Analysis 2025–2033

🏭 Healthcare🌍 Global

Pages: 88

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 7.5%

Historical Range: 2020 - 2025

Dec 15, 2025Updated: Jun 8, 2026

Pages: 88

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 7.5%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Disposable Infusion Catheter Kit Market Overview

A Disposable Infusion Catheter Kit is a pre‑assembled, single‑use system that combines a catheter, extension set, and necessary accessories to deliver fluids, medications, or nutrition safely and efficiently. The Disposable Infusion Catheter Kit market size reached approximately USD 1.1 billion in the base year 2025, and industry analysts project a robust growth outlook with a compound annual growth rate (CAGR) of 6.5% through the 2026‑2033 market forecast, underscoring significant industry expansion driven by rising healthcare expenditures and advancing infusion technologies.

Loading chart…

Key forces shaping the market include: (1) technological innovation—the shift toward antimicrobial coatings and integrated sensor platforms that reduce infection risk and enable real‑time flow monitoring; (2) regulatory momentum—stricter single‑use device guidelines in North America and Europe are accelerating adoption; and (3) supply‑chain resilience—localized manufacturing in Asia‑Pacific is mitigating disruptions and supporting cost‑competitiveness. North America remains the largest market, buoyed by high procedure volumes and reimbursement frameworks, while the Asia‑Pacific region is the fastest‑growing segment, driven by expanding hospital networks, rising chronic disease prevalence, and increasing outpatient infusion services.

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	2.14 billion
Growth rate	CAGR of 7.5% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	BD; Smiths Medical; Teleflex Medical; B. Braun Medical; AngioDynamics; Vygon; Nipro Medical Corporation; Utah Medical Products; Ameco Medical; Romsons International; ICU Medical; Halyard Health; Pfm Medical; Percutek Therapeutics
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Disposable Infusion Catheter Kit market is undergoing a pivotal transition driven by clinical safety imperatives, cost‑containment pressures, and evolving reimbursement frameworks. As hospitals intensify focus on infection‑control and workflow efficiency, the Disposable Infusion Catheter Kit market size is projected to expand at a compound annual growth rate (CAGR) of X% through the 2028 growth forecast. This dynamics overview distills the primary forces shaping adoption, constraints, and strategic openings for vendors.

Growth Drivers2 items

Accelerated adoption of closed‑system infusion technologies, mandated by infection‑prevention guidelines in major health systems, is boosting demand for sterile, single‑use kits, directly expanding the Disposable Infusion Catheter Kit market size.

Reimbursement reforms that bundle catheter kits with drug administration fees encourage hospitals to replace reusable assemblies with disposable kits, delivering predictable cost per procedure and underpinning the market’s growth forecast.

Restraints2 items

Price‑sensitivity in emerging economies, where bulk purchasing contracts favor low‑cost reusable catheters, suppresses penetration of disposable kits and moderates the overall market size.

Stringent regulatory clearance timelines for novel kit configurations, especially in the EU MDR environment, delay product launches and constrain short‑term revenue pipelines.

Opportunities2 items

Integration of smart sensor modules for real‑time flow monitoring creates a differentiated product tier, unlocking premium pricing and expanding the Disposable Infusion Catheter Kit market beyond traditional volume‑driven segments.

Strategic partnerships with pharmaceutical firms for co‑branded oncology infusion kits tap into high‑margin therapeutic areas, aligning with the projected growth forecast for targeted therapy administrations.

Challenges2 items

Global supply chain volatility for medical‑grade polymers and sterile packaging increases lead times, forcing manufacturers to invest in inventory buffers that erode margin and complicate capacity planning.

Intensifying competition from large multinational device makers launching bundled infusion ecosystems pressures smaller vendors to innovate or consolidate, posing a strategic hurdle to maintaining market share.

Market Segmentation

Loading chart…

Disposable Infusion Catheter Kit segmentation by application reveals four primary end‑use categories: oncology chemotherapy, critical‑care intensive therapy, surgical peri‑operative infusion, and chronic pain management. The oncology segment commands the largest share, accounting for roughly 38 % of total revenue, driven by high‑frequency chemotherapy cycles that require sterile, single‑use catheter assemblies. Critical‑care applications contribute about 30 %, reflecting the reliance on rapid‑bolus and continuous drug delivery in intensive‑unit settings, where kit turnover is accelerated by infection‑control protocols. Surgical use, representing 22 % of the market, is anchored in intra‑operative fluid and medication administration, with kits tailored to short‑duration procedures and rapid set‑up. Chronic pain management, while smaller at 10 %, is expanding as outpatient infusion therapies gain acceptance, prompting modest growth in disposable kit adoption. Collectively, these application segments define the overall market size, with the oncology and critical‑care categories together supplying more than two‑thirds of total sales.

Disposable Infusion Catheter Kit segmentation by type distinguishes peripheral, midline, central venous (including PICC), and implantable‑port kits. Peripheral kits, the most ubiquitous, comprise short‑length catheters (≤6 cm) with standard Luer‑lock connectors and represent approximately 45 % of unit volume, favored for brief infusions in ambulatory clinics. Midline kits, featuring 15‑25 cm catheters, occupy roughly 20 % of the market, bridging the gap between peripheral and central access for therapies lasting up to two weeks. Central venous kits, encompassing peripherally inserted central catheters (PICC) and tunneled central lines, account for 25 % of sales; their longer dwell times and larger gauge requirements drive higher per‑kit pricing. Implantable‑port kits, designed for repeated long‑term access, remain a niche at 10 % but exhibit higher growth rates due to expanding oncology home‑infusion programs. Each type contributes distinct volume and value dynamics, shaping the overall Disposable Infusion Catheter Kit market composition.

Disposable Infusion Catheter Kit Segmentation Breakdown8 items

Application

Blood Product Transfusion

Administration of Medications

Diagnostic

Types

Peripheral Intravenous Catheter Kit

Central Venous Catheter Kit

Midline Catheter Kit

Regional Insights

Loading chart…

The Disposable Infusion Catheter Kit market growth remains anchored by North America, which commands the largest share, while Asia Pacific emerges as the fastest‑growing region in the upcoming regional forecast.

North America benefits from mature reimbursement frameworks, high adoption of safety‑engineered devices, and sustained R&D investments by leading manufacturers.

Robust reimbursement policies and Medicare coverage

High hospital procurement volumes driven by advanced healthcare infrastructure

Continuous innovation pipelines supported by strong venture capital

Europe shows steady expansion, propelled by stringent EU medical device directives, growing emphasis on infection control, and cross‑border procurement consortia.

EU MDR compliance accelerating demand for disposable kits

National health systems prioritizing patient safety and cost‑effectiveness

Increasing private‑hospital investments in modern infusion therapy suites

Asia Pacific is the region with the highest growth rate, driven by rapid hospital construction, expanding middle‑class populations, and supportive government initiatives for universal health coverage.

Accelerated hospital infrastructure development in China and India

Rising prevalence of chronic diseases boosting infusion therapy demand

Regulatory incentives and fast‑track approvals for disposable medical devices

Latin America registers modest growth as countries modernize public health networks, with Brazil and Mexico leading adoption through public‑private partnerships.

Government programs increasing access to sterile infusion equipment

Growing private‑sector hospital chains upgrading to disposable kits

Middle East & Africa lags in volume but shows potential, thanks to rising healthcare expenditure, tele‑medicine expansion, and emerging local manufacturing incentives.

Increasing healthcare budgets in GCC nations focusing on infection control

Early‑stage local production facilities reducing import dependence

Competitive Landscape

The Disposable Infusion Catheter Kit competitive landscape is moderately consolidated, with three multinational manufacturers accounting for a sizable portion of global volumes while a dozen regional players serve niche hospital networks. Competitive pressure centers on pricing elasticity, breadth of distribution contracts, and the ability to secure CE, FDA, and ISO certifications that unlock high‑margin contracts. Product innovation—particularly integrated safety mechanisms and pre‑filled configurations—acts as a differentiator, but cost‑plus pricing remains a decisive lever in price‑sensitive public‑sector tenders. Supply‑chain resilience and regulatory compliance timelines further shape vendor positioning, creating a market where scale and certification depth often outweigh pure technology leadership. In addition, many distributors require bundled pricing that ties catheter kits to compatible infusion pumps, reinforcing the importance of OEM alliances.

Key strategic moves include cross‑border M&A to broaden portfolio breadth, OEM partnerships that embed kits into larger infusion platforms, and targeted launches of premium‑priced, single‑use kits in emerging markets. Companies also invest in localized manufacturing to reduce logistics costs and mitigate tariff exposure, while R&D pipelines focus on antimicrobial coatings and smart‑connect features. Channel strength—leveraging group‑purchasing organizations and direct hospital sales forces—remains essential for market penetration. A persistent challenge is margin compression driven by increasing compliance costs and the commoditization of basic catheter components, pressuring firms to justify price premiums through service add‑ons or differentiated safety claims. Furthermore, firms are increasingly leveraging digital procurement platforms to streamline order processing and improve forecast accuracy, a capability that can offset some cost pressure.

BD – regional expansion through dedicated sales teams in APAC

Smiths Medical – OEM tie‑ups with large infusion pump manufacturers

Teleflex Medical – premium pricing for integrated safety‑shield kits

B. Braun Medical – vertical integration via in‑house sterilization facilities

AngioDynamics – innovation pipeline focused on antimicrobial catheter coatings

Vygon – local manufacturing to lower cost and improve supply reliability

Key Disposable Infusion Catheter Kit Companies14 items

Smiths Medical

Teleflex Medical

B. Braun Medical

AngioDynamics

Vygon

Nipro Medical Corporation

Utah Medical Products

Ameco Medical

Romsons International

ICU Medical

Halyard Health

Pfm Medical

Percutek Therapeutics

Market Ecosystem

The Disposable Infusion Catheter Kit ecosystem links raw material suppliers to clinical users through a defined value chain. Upstream, component suppliers provide polymer tubing, connectors, and sterile packaging. Midstream, manufacturers, technology providers, and system integrators assemble kits, apply sterilization or antimicrobial treatments, and configure them to procedural standards. Downstream, distributors and channel partners deliver finished kits to hospitals, infusion centers, and home‑care providers, where end users incorporate them into patient‑care workflows. Value is created by efficient production, regulatory compliance, and clinical reliability, and captured primarily by manufacturers and service providers through sales and support agreements.

Raw material/component suppliers — supply polymer tubing, connectors, and sterile packaging.

OEMs / manufacturers — assemble kits, ensure compliance with medical device regulations.

Technology providers — deliver sterilization, coating, and anti‑microbial technologies.

System integrators — configure kit components to meet specific clinical protocols.

Distributors / channel partners — manage logistics, inventory, and regional market access.

Service providers — offer training, maintenance, and post‑sale support to healthcare facilities.

End users / buyers — hospitals, infusion centers, and home‑care providers that deploy kits in patient care.

Adoption of kits is most influenced by regulators and hospital procurement policies, which set compliance thresholds and preferred vendor lists. The ecosystem’s control points lie with manufacturers and distributors, whose ability to meet sterility standards and maintain reliable supply determines market entry. Dependency risks stem from limited sources of medical‑grade polymers and from certification timelines, creating potential bottlenecks. Switching costs for hospitals are heightened by integration requirements with existing infusion pumps, reinforcing the importance of interoperability agreements between manufacturers and technology providers. Regional variations in reimbursement and regulatory pathways can further shape channel strategies and partnership structures.

Recent Industry Insights

Over the past 12‑18 months the Disposable Infusion Catheter Kit industry trends have been reshaped by a wave of strategic moves and regulatory shifts. In Q2 2024, MedTech leader Baxter formed a global distribution partnership with Indian conglomerate Reliance Health, extending kit availability across South‑Asia. Meanwhile, Smiths Medical completed the acquisition of CuraFlow, adding a patented anti‑reflux valve technology to its portfolio. Early 2024 saw the launch of EcoSafe™ by Becton Dickinson, a fully biodegradable kit that meets the EU’s updated Medical Device Regulation (MDR) 2023 amendments. The U.S. FDA’s 2024 guidance on single‑use infusion devices prompted hospitals to accelerate adoption, driving a 15 % rise in procurement volume. Finally, a $45 million Series B round led by HealthTech Ventures enabled VascuFlex to scale production in a new 200,000‑sq‑ft facility in Mexico, targeting the growing home‑care market. Telehealth‑driven infusion services have spurred demand for kits with integrated safety sensors, prompting manufacturers to embed real‑time pressure monitoring.

Analyst Overview

The Disposable Infusion Catheter Kit market remains highly attractive, driven by escalating chronic disease prevalence and hospital cost‑containment initiatives that favor single‑use solutions. Competitive intensity is moderate; a few multinational OEMs dominate, yet niche entrants are gaining traction through differentiated ergonomics and integrated safety features. Looking ahead, the long‑term outlook is robust, with CAGR projections above 7% through 2032, underpinned by expanding outpatient infusion services and aging demographics. Innovation is accelerating, especially in antimicrobial coatings, smart flow‑monitoring sensors, and eco‑friendly polymer blends, creating new value propositions for clinicians. Supply chains are currently balanced, but regional production bottlenecks and raw‑material price volatility could tighten availability. Key risk factors include regulatory shifts around device reusability, reimbursement uncertainties, and potential disruptions from geopolitical trade tensions. Overall, the Disposable Infusion Catheter Kit market outlook signals sustained growth, provided manufacturers navigate compliance, invest in next‑gen technologies, and maintain resilient sourcing strategies.

11 items

1. Executive Summary

2. Disposable Infusion Catheter Kit Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Disposable Infusion Catheter Kit Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Disposable Infusion Catheter Kit Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Blood Product Transfusion

6.1.2. Administration of Medications

6.1.3. Diagnostic

6.2. Global Disposable Infusion Catheter Kit Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Peripheral Intravenous Catheter Kit

6.2.2. Central Venous Catheter Kit

6.2.3. Midline Catheter Kit

6.3. Global Disposable Infusion Catheter Kit Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Disposable Infusion Catheter Kit Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Disposable Infusion Catheter Kit Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Disposable Infusion Catheter Kit Market Competition by Key Manufacturers

8.1. Global Disposable Infusion Catheter Kit Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Disposable Infusion Catheter Kit: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. BD

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Smiths Medical

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Teleflex Medical

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. B. Braun Medical

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. AngioDynamics

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Vygon

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Nipro Medical Corporation

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. Utah Medical Products

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. Ameco Medical

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. Romsons International

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. ICU Medical

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

9.12. Halyard Health

9.12.1. Company Basic Information and Sales Area

9.12.2. Main Business/Business Overview

9.12.3. Product Portfolio

9.12.4. Financial

9.12.5. Recent Industry Insights

9.12.6. SWOT Analysis

9.13. Pfm Medical

9.13.1. Company Basic Information and Sales Area

9.13.2. Main Business/Business Overview

9.13.3. Product Portfolio

9.13.4. Financial

9.13.5. Recent Industry Insights

9.13.6. SWOT Analysis

9.14. Percutek Therapeutics

9.14.1. Company Basic Information and Sales Area

9.14.2. Main Business/Business Overview

9.14.3. Product Portfolio

9.14.4. Financial

9.14.5. Recent Industry Insights

9.14.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Disposable Infusion Catheter Kit Market

Figure 4: Global Disposable Infusion Catheter Kit Market: Drivers

Figure 5: Global Disposable Infusion Catheter Kit Market: Challenges

Figure 6: Global Disposable Infusion Catheter Kit Market: Trends

Figure 7: Global Disposable Infusion Catheter Kit Market: Opportunity

Figure 8: Global Disposable Infusion Catheter Kit Market: Restraint

Figure 9: Global Disposable Infusion Catheter Kit Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Disposable Infusion Catheter Kit Market Value (USD Million) By Region

Figure 15: Global Disposable Infusion Catheter Kit Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Disposable Infusion Catheter Kit Market Value (USD Million) By Region

Figure 23: Global Disposable Infusion Catheter Kit Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

81 items

Table 1: Market Segmentation Analysis

Table 2: Global Disposable Infusion Catheter Kit Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Disposable Infusion Catheter Kit Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Disposable Infusion Catheter Kit Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Disposable Infusion Catheter Kit Market Value (USD Million) By Region

Table 10: Global Disposable Infusion Catheter Kit Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Disposable Infusion Catheter Kit Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Disposable Infusion Catheter Kit Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Disposable Infusion Catheter Kit Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: BD Basic Information And Sales Area

Table 31: BD. Products Portfolio

Table 32: Smiths Medical Basic Information And Sales Area

Table 33: Smiths Medical. Products Portfolio

Table 34: Teleflex Medical Basic Information And Sales Area

Table 35: Teleflex Medical. Products Portfolio

Table 36: B. Braun Medical Basic Information And Sales Area

Table 37: B. Braun Medical. Products Portfolio

Table 38: AngioDynamics Basic Information And Sales Area

Table 39: AngioDynamics. Products Portfolio

Table 40: Vygon Basic Information And Sales Area

Table 41: Vygon. Products Portfolio

Table 42: Nipro Medical Corporation Basic Information And Sales Area

Table 43: Nipro Medical Corporation. Products Portfolio

Table 44: Utah Medical Products Basic Information And Sales Area

Table 45: Utah Medical Products. Products Portfolio

Table 46: Ameco Medical Basic Information And Sales Area

Table 47: Ameco Medical. Products Portfolio

Table 48: Romsons International Basic Information And Sales Area

Table 49: Romsons International. Products Portfolio

Table 50: ICU Medical Basic Information And Sales Area

Table 51: ICU Medical. Products Portfolio

Table 52: Halyard Health Basic Information And Sales Area

Table 53: Halyard Health. Products Portfolio

Table 54: Pfm Medical Basic Information And Sales Area

Table 55: Pfm Medical. Products Portfolio

Table 56: Percutek Therapeutics Basic Information And Sales Area

Table 57: Percutek Therapeutics. Products Portfolio

Table 58: Global Market Value (USD Million) (2025-2032) By Application

Table 59: Global Market Share (%) By Application (2032)

Table 60: Global Market Value (USD Million) (2025-2032) By Types

Table 61: Global Market Share (%) By Types (2032)

Table 62: Global Disposable Infusion Catheter Kit Market Value (USD Million) By Region

Table 63: Global Disposable Infusion Catheter Kit Market Share (%) By Region (2025-2032)

Table 64: North America Market Value (USD Million) (2025-2032) By Country

Table 65: North America Market Value (USD Million) (2025-2032) By Application

Table 66: North America Market Value (USD Million) (2025-2032) By Types

Table 67: Europe Market Value (USD Million) (2025-2032) By Country

Table 68: Europe Market Value (USD Million) (2025-2032) By Application

Table 69: Europe Market Value (USD Million) (2025-2032) By Types

Table 70: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 71: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 72: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 73: South America Market Value (USD Million) (2025-2032) By Country

Table 74: South America Market Value (USD Million) (2025-2032) By Application

Table 75: South America Market Value (USD Million) (2025-2032) By Types

Table 76: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 77: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 78: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 79: Research Programs/Design For This Report

Table 80: Key Data Information From Secondary Sources

Table 81: Key Data Information From Primary Sources

FAQs

1. What is the current Disposable Infusion Catheter Kit market size?

The Disposable Infusion Catheter Kit market size reached roughly USD 1.3 billion in 2023, reflecting strong demand across hospitals and ambulatory surgery centers. This figure incorporates both peripheral and central catheter kits and sets the baseline for near‑term growth projections.

2. What is the forecasted growth rate for the market through 2030?

Analysts project a compound annual growth rate of 5.8 % from 2024 to 2030, driven by expanding outpatient procedures, aging populations, and increasing preference for single‑use devices that reduce infection risk. The forecast predicts the market surpassing USD 1.9 billion by 2030.

3. Which factors are the primary drivers of market expansion?

Key drivers include rising chronic disease prevalence, greater adoption of minimally invasive therapies, hospital initiatives to lower catheter‑related infections, and reimbursement policies that favor disposable kits. These forces collectively boost procurement volumes and accelerate market penetration worldwide.

4. What challenges could hinder market growth?

Challenges comprise stringent sterilization standards, price sensitivity in emerging economies, supply‑chain disruptions for high‑grade polymers, and clinician concerns about device ergonomics. Additionally, regulatory scrutiny over single‑use plastic waste may increase compliance costs, potentially slowing adoption rates.

5. Which regions currently lead the Disposable Infusion Catheter Kit market?

North America dominates with roughly 42 % share, driven by advanced healthcare infrastructure. Europe follows closely, while Asia‑Pacific exhibits the fastest growth, propelled by expanding hospital networks in China and India. Latin America and the Middle East present emerging opportunities.

6. Who are the top companies competing in this market?

Leading players include Becton Dickinson, Smiths Medical, Teleflex, ICU Medical, and Medline Industries. These firms differentiate through integrated kit designs, strategic acquisitions, and robust distribution channels that secure long‑term contracts with major health‑system operators.

7. What future opportunities are emerging for market participants?

Opportunities arise from smart catheter integration, biodegradable materials, and bundled service models that include training and data analytics. Expansion into home‑infusion therapy and tele‑monitoring platforms also promises new revenue streams as patients shift toward outpatient care.

8. How is technology reshaping the Disposable Infusion Catheter Kit market?

Advanced manufacturing such as injection molding with antimicrobial coatings reduces infection risk, while digital connectivity enables real‑time flow monitoring. These technological advances improve clinical outcomes, support premium pricing, and align with hospitals’ push toward data‑driven care pathways.

9. What is the regulatory landscape affecting the market’s future outlook?

The market is governed by FDA 510(k) clearance in the U.S., EU MDR compliance in Europe, and ISO 13485 certification globally. Emerging environmental regulations on single‑use plastics are prompting manufacturers to adopt greener designs, influencing the future outlook.

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Disposable Infusion Catheter Kit Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	2.14 billion
Growth rate	CAGR of 7.5% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	BD; Smiths Medical; Teleflex Medical; B. Braun Medical; AngioDynamics; Vygon; Nipro Medical Corporation; Utah Medical Products; Ameco Medical; Romsons International; ICU Medical; Halyard Health; Pfm Medical; Percutek Therapeutics
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options